SEC FORM 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0104
Expires:	December 31, 2014
Estimated average burden
hours per response:		0.5

1. Name and Address of Reporting Person ^*

Aebli Christopher T.

(Last)

(First)

(Middle)

C/O L3HARRIS TECHNOLOGIES, INC.

1025 W. NASA BOULEVARD

(Street)

MELBOURNE

32919

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/17/2026

3. Issuer Name and Ticker or Trading Symbol
L3HARRIS TECHNOLOGIES, INC. /DE/ [ LHX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Pres., Comm & Spect. Dominance

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, Par Value $1.00	4,432	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	02/28/2023⁽¹⁾	02/28/2030⁽¹⁾	Common Stock, Par Value $1.00	1,631	197.73	D
Stock Option (Right to Buy)	02/26/2024⁽¹⁾	02/26/2031⁽¹⁾	Common Stock, Par Value $1.00	1,364	181.91	D
Stock Option (Right to Buy)	02/25/2025⁽¹⁾	02/25/2032⁽¹⁾	Common Stock, Par Value $1.00	1,204	233.51	D
Stock Option (Right to Buy)	02/24/2026⁽¹⁾	02/24/2033⁽¹⁾	Common Stock, Par Value $1.00	1,255	210.15	D
Stock Option (Right to Buy)	02/23/2027⁽²⁾	02/23/2034⁽²⁾	Common Stock, Par Value $1.00	1,464	214.45	D
Stock Option (Right to Buy)	02/28/2028⁽³⁾	02/28/2035⁽³⁾	Common Stock, Par Value $1.00	1,779	206.11	D
Stock Option (Right to Buy)	02/26/2029⁽⁴⁾	02/26/2036⁽⁴⁾	Common Stock, Par Value $1.00	1,087	355.16	D
Restricted Stock Units	⁽⁵⁾	⁽⁵⁾	Common Stock, Par Value $1.00	350	0	D
Restricted Stock Units	⁽⁶⁾	⁽⁶⁾	Common Stock, Par Value $1.00	425	0	D
Restricted Stock Units	⁽⁷⁾	⁽⁷⁾	Common Stock, Par Value $1.00	282	0	D

Explanation of Responses:

1. Options to purchase shares of Issuer's common stock, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.

2. Options to purchase shares of Issuer's common stock, 488 of which became exercisable on 2/23/2025, 488 of which became exercisable on 2/23/2026 and 488 which become exercisable on 2/23/2027, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.

3. Options to purchase shares of Issuer's common stock, 593 which became exercisable on 2/28/2026, 593 which become exercisable on 2/28/2027 and 593 which become exercisable on 2/28/2028, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.

4. Options to purchase shares of Issuer's common stock, 362 which become exercisable on 2/26/2027, 362 which become exercisable on 2/26/2028 and 363 which become exercisable on 2/26/2029, subject to continued employment (with certain exceptions) and the terms and conditions of the stock option award agreement.

5. Award of restricted stock units, which vest on 2/23/2027, subject to continued employment (with certain exceptions) and the terms and conditions of the restricted unit award agreement. Each restricted stock unit represents a contingent right to receive 1 share of common stock, with vested units settled in shares of Issuer's common stock.

6. Award of restricted stock units, which vest on 2/28/2028, subject to continued employment (with certain exceptions) and the terms and conditions of the restricted unit award agreement. Each restricted stock unit represents a contingent right to receive 1 share of common stock, with vested units settled in shares of Issuer's common stock.

7. Award of restricted stock units, which vest on 2/26/2029, subject to continued employment (with certain exceptions) and the terms and conditions of the restricted unit award agreement. Each restricted stock unit represents a contingent right to receive 1 share of common stock, with vested units settled in shares of Issuer's common stock.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

	By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Christopher T. Aebli	08/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-24